These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Treatment of low-risk metastatic gestational trophoblastic tumors with single-agent chemotherapy. Roberts JP; Lurain JR Am J Obstet Gynecol; 1996 Jun; 174(6):1917-23; discussion 1923-4. PubMed ID: 8678159 [TBL] [Abstract][Full Text] [Related]
15. Guidelines for the stratification of patients recruited to trials of therapy for low-risk gestational trophoblastic tumor. Nevin J; Silcocks P; Hancock B; Coleman R; Nakielny R; Lorigan P Gynecol Oncol; 2000 Aug; 78(2):92-6. PubMed ID: 10926786 [TBL] [Abstract][Full Text] [Related]
16. Actinomycin d versus methotrexate-folinic acid as the treatment of stage I, low-risk gestational trophoblastic neoplasia: a randomized controlled trial. Lertkhachonsuk AA; Israngura N; Wilailak S; Tangtrakul S Int J Gynecol Cancer; 2009 Jul; 19(5):985-8. PubMed ID: 19574798 [TBL] [Abstract][Full Text] [Related]
17. Treatment results of methotrexate and folinic acid as primary chemotherapy for nonmetastatic gestational trophoblastic neoplasia. Srisomboon J; Suprasert P; Phongnarisorn C; Charoenkwan K; Siriaree S; Cheewakriangkrai C; Tantipalakorn C; Kietpeerakool C J Med Assoc Thai; 2005 Jul; 88(7):886-90. PubMed ID: 16241014 [TBL] [Abstract][Full Text] [Related]
18. Medium-dose methrotrexate/folinic acid regimen in the chemotherapy of gestational trophoblastic disease. Khoo SK; Jones IS Med J Aust; 1980 Apr; 1(7):317-20. PubMed ID: 6248746 [TBL] [Abstract][Full Text] [Related]